Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Gentian Diagnostics ASA ( (DE:6FK) ) is now available.
Holta Invest AS, a close associate of Gentian Diagnostics ASA board member Espen Tidemann Jørgensen, has sold 1,228,502 shares in the company at NOK 46.50 per share. This transaction, subject to EU Market Abuse Regulation and Norwegian Securities Trading Act, could impact Gentian’s market perception and shareholder value.
More about Gentian Diagnostics ASA
Gentian Diagnostics ASA operates in the diagnostics industry, focusing on the development and production of diagnostic tests. The company is known for its innovative diagnostic solutions, catering to a global market with a focus on improving healthcare outcomes.
YTD Price Performance: 23.12%
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €65.18M
For a thorough assessment of 6FK stock, go to TipRanks’ Stock Analysis page.